NICHD Neonatal Research Network

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, NICHD Neonatal Research Network sits in the top decile of US sponsors by registered trial count (#334 of 15,742 sponsors by registered trial count).

61 total trials 4 currently recruiting 45 completed later-stage tilt top decile by trial count

NICHD Neonatal Research Network: 61 sponsored US clinical trials, 4 recruiting.

NICHD Neonatal Research Network sponsors 61 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 45 completed. 21 of these trials are in Phase 3-4 (later-stage) and 13 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Infant, Small for Gestational Age, with 13 trials.

Top-decile sponsor footprint

NICHD Neonatal Research Network ranks in the top decile of sponsors by registered trial count (#334 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 48/100

45 of 54 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

61 total, page 2 of 2

COMPLETED

Growth Observational Study

NCT01203475
COMPLETED

Development of Standards for the New Ballard Maturation Score

NCT01203449
COMPLETED Phase 2

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity

NCT01203436
COMPLETED Phase 3

Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)

NCT00009646
COMPLETED

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

NCT01203423
COMPLETED

The Maternal Lifestyle Study (MLS)

NCT00059540
COMPLETED Phase 3

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

NCT00009620
COMPLETED Phase 3

Dexamethasone Therapy in VLBW Infants at Risk of CLD

NCT00011362
COMPLETED

Prediction of Jaundice in Term Infants

NCT01203410
COMPLETED Phase 2

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

NCT01203358
COMPLETED Phase 2

Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection

NCT01203345
← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 8
Phase 3 21

Therapeutic Areas

Infant, Small for Gestational Age 13
Infant, Premature 12
Infant, Newborn 11
Infant, Low Birth Weight 10
Bronchopulmonary Dysplasia (BPD) 3
Infant, Newborn, Diseases 3
Infant, Extremely Low Birth Weight 2
Neonatal 2
Bronchopulmonary Dysplasia 2
Cerebral Palsy 2

Where NICHD Neonatal Research Network enrollment is open (later-stage tilt)

4 recruiting of 61 indexed (7% open); 45 completed (74%).

Phase mix: 21 late (III/IV) vs 13 early (I/II) (later-stage heavy).

Top condition: Infant, Small for Gestational Age (13 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

NICHD Neonatal Research Network: open-pipeline peers nationwide

Peers matched on 61 registered trials and 7% open enrollment, not the therapeutic-area sidebar.

NICHD Neonatal Research Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%5%10%15%20%25% Total trials Recruiting share NICHD Neonatal Research NetworkEndo USA Inc., a Keenova Therapeutics CompanyOregon Research InstitutePower Life SciencesHenry M. Jackson Foundation for the Advancement of Military MedicineNational Institutes of Health Clinical Center (CC)Alliance for Clinical Trials in OncologyInsmed IncorporatedBaylor Breast Care Center
NICHD Neonatal Research Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

NICHD Neonatal Research Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 61 trials (± recruiting share)

Sponsors near 7% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this NICHD Neonatal Research Network page

61 registered trials is a research-attention snapshot, not an endorsement of NICHD Neonatal Research Network or any single study.

  • 4 of NICHD Neonatal Research Network's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Infant, Small for Gestational Age is the condition NICHD Neonatal Research Network studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Infant, Small for Gestational Age trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

NICHD Neonatal Research Network pipeline card: 61 registered trials from official public datasets.Report a data error.